PVR and lung adenocarcinoma: Data from the lung adenocarcinoma cohort from TCGA showed that patients with high SOCS1 expression showed low CD155 expression, and patients with low SOCS1 expression displayed high CD155 expression (Figure 3A), suggesting that SOCS1 may negatively regulate CD155 expression.